Breast cancer interactions with osteoclasts generate osteoclast-tumor hybrid-like cells through dynamic non-canonical cell fusion and cell-in-cell processes
Preprint
Abstract
Macrophages/osteoclasts are highly fusogenic cells that interact closely with bone-metastatic breast cancer cells. These cancer cells adapt to bone microenvironments by undergoing osteomimicry, acquiring bone-like phenotypes. Exploration using human breast cancer-bone metastases dataset revealed that a small population of epithelial breast cancer cells express osteoclast-like and osteomimicry genes at the single-cell level. Cell fusion and cell-in-cell (CIC) processes are two uncommon yet prognostically significant mechanisms in cancer. We showed that co-culture between murine breast cancer cells and osteoclasts yielded a unique osteoclast phenotype through dynamic cell-in-cell (CIC) interactions and fusion-like behaviours between pre-osteoclasts/mature osteoclasts and breast tumor cells, resulting in osteoclast–tumor hybrid-like cells. These tumor cell interactions characterized by membrane retention and nuclear adjacency to host nuclei were consistently observed throughout osteoclast differentiation. Single-cell sequencing analysis and interpretative assays on hybrid-like cells revealed altered extracellular matrix (ECM) modification processes, immunoregulatory, and cancer-associated pathways compared to unfused osteoclasts. Tumor cells co-cultured with osteoclasts expressed hematopoietic and osteoclast-lineage factors more strongly than tumor cells cultured alone with their effects amplified under direct cell-cell contact. The presence of these hybrid-like cells was validated in human breast cancer-bone metastases. We propose that disseminated bone-tropic breast cancer cells were stimulated by osteoclasts to undergo a non-canonical, dynamic osteoclast differentiation and CIC formation to form hybrid-like cells that may facilitate bone metastatic lesions.Keywords
Funding Information
- Croucher Foundation (9509002)
- Croucher Foundation (9500032)
- The Science and Technology Innovation Committee of Shenzhen Municipality (JCYJ20210324133813036)
- Hong Kong Research Grants Council (C7008-22G)
- Hong Kong Research Grants Council (11103523)
- Tung's Biomedical Sciences Centre (9609306)
- City University of Hong Kong (7005313)
- City University of Hong Kong (7005518)
- City University of Hong Kong (7005740)
- City University of Hong Kong (7005873)
This publication has 36 references indexed in Scilit:
- Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicineAnnals of Oncology, 2022
- Emerging Players in Prostate Cancer–Bone Niche CommunicationTrends in Cancer, 2021
- Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodelingBone Research, 2021
- Molecular mechanisms and clinical management of cancer bone metastasisBone Research, 2020
- Vascular mimicry: Triggers, molecular interactions and in vivo models2020
- Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidenceThe Breast, 2016
- The role of osteoclasts in breast cancer bone metastasisJournal of Bone Oncology, 2016
- Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer–host partnership?The Journal of Pathology, 2006
- Mechanisms of osteolytic bone metastases in breast carcinomaCancer, 2003
- Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysisJournal of Orthopaedic Research, 1996